Last updated: February 25, 2026
What are the criteria for patentability of biopharmaceutical inventions in Chile?
Chile relies on standard patentability requirements: novelty, inventive step, and industrial applicability. The Chilean Patent Law (Law No. 19,039) aligns with the TRIPS Agreement standards but introduces specific considerations for biopharmaceuticals.
Novelty
- The invention must be new, meaning it is not disclosed or used publicly before the filing date or priority date.
- Prior art includes publications, public demonstrations, or commercial use worldwide, with exceptions for disclosures within 12 months before filing if filed in subsequent patent applications.
Inventive Step
- The biopharmaceutical invention cannot be obvious to a person skilled in the art, considering existing knowledge and prior patents.
- Demonstrations of inventive step often require detailed technical evidence given the complexity of biological inventions.
Industrial Applicability
- The invention must have a practical application in industry, including medical or pharmaceutical contexts.
- Purely theoretical or diagnostic methods without practical utility do not qualify.
How does Chile assess patentability of biopharmaceutical inventions?
Chile's Patent Office (INAPI) applies the following considerations:
- Similar to other jurisdictions, patentability depends on thorough examination, including a substantive review of prior art.
- Emphasis on the technical novelty and inventive step of the biological material, processes, or formulations.
- Clear demonstration that the biological invention is sufficiently disclosed to enable others skilled in the field to replicate it.
Non-Patentable Biopharmaceuticals
- Naturally occurring substances or methods of medical treatment are generally not patentable, aligning with global trends.
- Pathogenic micro-organisms are patentable if isolated or purified and if the invention differs significantly from natural occurrence.
What are the enforceability considerations for biopharmaceutical patents in Chile?
Patent Validity
- Maintains a 20-year term from the filing date; enforceability hinges on maintenance payments and the patent's validity.
- The validity can be challenged through nullity proceedings based on lack of novelty, inventive step, or insufficient disclosure.
Patent Infringement
- Strictly enforced, with rights to prevent third parties from manufacturing, using, or selling patented biopharmaceuticals without authorization.
- Infringing parties face injunctions, damages, and possibly criminal sanctions for infringement.
Challenges to Enforcement
- Patent trolls or non-practicing entities may attempt to challenge patent validity; courts evaluate prior art and disclosure.
- Patent owners must monitor for potential infringement and be prepared for complex litigation, especially in high-value biological products.
What is the scope of claims in biopharmaceutical patents?
Claim Types
- Product Claims: Cover isolated biological molecules such as proteins, antibodies, or nucleic acids.
- Process Claims: Cover methods of manufacturing or extracting biopharmaceuticals.
- Use Claims: Cover specific therapeutic indications or applications.
Claim Drafting Strategies
- Broad claims targeting the biological entity or process, balanced with narrow claims to resist invalidation attacks.
- Specification must sufficiently describe the claimed invention to meet sufficiency requirements.
- Claims should specify the biological or chemical features that distinguish the invention from prior art.
Limitations on Claims
- Claims cannot pre-empt all methods of treatment; method claims for new surgical or therapeutic procedures are not patentable in Chile.
- Claims that relate to natural products, unless significantly modified or processed, are difficult to patent.
Policy and procedural considerations
- Chile adopts an initial examination process, with examination requests to be filed within three years from the priority date.
- Inventors and applicants should submit comprehensive disclosures, including biological data and detailed process descriptions.
- Patent applications are published 18 months after the filing date, providing transparency and opportunity for third-party oppositions.
Closing Summary
Chile's patent environment for biopharmaceuticals adheres to international standards but emphasizes detailed disclosure, clear scope, and novelty. Patents are enforceable for 20 years, with scope defined through strategic claim drafting. Challenges to validity and infringement are actively pursued through formal legal processes.
Key Takeaways
- Chile grants patents for biopharmaceutical inventions that meet novelty, inventive step, and industrial applicability, with special attention to biological material disclosures.
- Enforceability depends on maintaining validity; infringement enforcement follows strict legal procedures.
- The scope of claims differs across product, process, and use claims, with limitations to prevent broad monopolies over natural substances.
- Patents require detailed disclosures early in the application process, with publication at 18 months.
- Judicial and administrative mechanisms support patent enforcement, but challenges often involve prior art and disclosure issues.
FAQs
1. Can naturally occurring biological substances be patented in Chile?
Yes, if they are isolated, purified, or significantly modified from their natural state, and if the invention demonstrates novelty and inventive step.
2. How long does patent protection last for biopharmaceuticals in Chile?
20 years from the filing date, subject to maintenance fee payments.
3. Are method-of-treatment patents available in Chile?
No, methods of medical treatment are generally not patentable.
4. What is the typical process to enforce a biopharmaceutical patent in Chile?
Initiate legal action for infringement, potentially combined with nullity proceedings if validity is questioned.
5. How detailed must the disclosure be for biopharmaceutical patent applications?
It must enable skilled persons to reproduce the invention, including biological data, process descriptions, and specific features distinguishing it from prior art.
References
- Chilean Patent Law No. 19,039.
- World Intellectual Property Organization. (2022). Patent information practices in Chile.
- WIPO. (2022). Guide to biopharmaceutical patent protection.
- INAPI. (2023). Patent examination guidelines.
